Impact of COVID-19 pandemic on carbapenem-resistant Enterobacterales incidence in the South-East Asia region: an observational study

Linn KZ 1 , Sutjipto S 1 , Ng OT 1 , Teo J 2 , Cherng BPZ 3 , Tan TY 4 Show all authors , Pada SK 5 , Ooi ST 6 , Smitasin N 2 , Thoon KC 7 , Huan X 1 , De PP 8 , Chan D 5 , Tee NWS 2 , Ang M 1 , Hsu LY 9 , Lin RTP 9 , Ng TY 10 , Deepak RN 6 , Koh TH 3 , Apisarnthanarak A 11 , Ponnampalavanar S 12 , Venkatachalam I 3 , Marimuthu K 1

Affiliations 

  • 1 National Centre for Infectious Diseases, Singapore, Singapore
  • 2 National University Hospital and National University Health System, Singapore, Singapore
  • 3 Singapore General Hospital, Singapore, Singapore
  • 4 Changi General Hospital, Singapore, Singapore
  • 5 Ng Teng Fong General Hospital, Singapore, Singapore
  • 6 Khoo Teck Puat Hospital, Singapore, Singapore
  • 7 Duke-NUS Medical School, National University of Singapore, Singapore, Singapore
  • 8 Tan Tock Seng Hospital, Singapore, Singapore
  • 9 Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore, Singapore
  • 10 Sengkang General Hospital, Singapore, Singapore
  • 11 Thammasat University Hospital, Bangkok, Thailand
  • 12 University of Malaya Medical Centre, Kuala Lumpur, Malaysia
Antimicrob Steward Healthc Epidemiol, 2023;3(1):e208.
PMID: 38156208 DOI: 10.1017/ash.2023.477

Abstract

The COVID-19 pandemic led to an initial increase in the incidence of carbapenem-resistant Enterobacterales (CRE) from clinical cultures in South-East Asia hospitals, which was unsustained as the pandemic progressed. Conversely, there was a decrease in CRE incidence from surveillance cultures and overall combined incidence. Further studies are needed for future pandemic preparedness.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications